GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Universal Ibogaine Inc (TSXV:IBO) » Definitions » EBITDA Margin %

Universal Ibogaine (TSXV:IBO) EBITDA Margin % : -16.81% (As of Jan. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Universal Ibogaine EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Universal Ibogaine's EBITDA for the three months ended in Jan. 2024 was C$-0.10 Mil. Universal Ibogaine's Revenue for the three months ended in Jan. 2024 was C$0.59 Mil. Therefore, Universal Ibogaine's EBITDA margin for the quarter that ended in Jan. 2024 was -16.81%.


Universal Ibogaine EBITDA Margin % Historical Data

The historical data trend for Universal Ibogaine's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Universal Ibogaine EBITDA Margin % Chart

Universal Ibogaine Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Jul22 Jul23
EBITDA Margin %
Get a 7-Day Free Trial - - - -948.83 -188.45

Universal Ibogaine Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1,675.61 -83.88 -29.64 -12.38 -16.81

Competitive Comparison of Universal Ibogaine's EBITDA Margin %

For the Biotechnology subindustry, Universal Ibogaine's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Universal Ibogaine's EBITDA Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Universal Ibogaine's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Universal Ibogaine's EBITDA Margin % falls into.



Universal Ibogaine EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Universal Ibogaine's EBITDA Margin % for the fiscal year that ended in Jul. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Jul. 2023 )/Revenue (A: Jul. 2023 )
=-1.941/1.03
=-188.45 %

Universal Ibogaine's EBITDA Margin % for the quarter that ended in Jan. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Jan. 2024 )/Revenue (Q: Jan. 2024 )
=-0.099/0.589
=-16.81 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Universal Ibogaine  (TSXV:IBO) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Universal Ibogaine EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Universal Ibogaine's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Universal Ibogaine (TSXV:IBO) Business Description

Traded in Other Exchanges
Address
400 3rd Avenue South west, Suite 1470, Calgary, AB, CAN, T2P 4H2
Universal Ibogaine Inc develops a platform of addiction treatment clinics, which use ibogaine as a primary modality for the interruption and ideally cessation of addictions to primarily opioids such as oxycodone, heroin, fentanyl, as well as alcohol, cocaine, and other stimulants. It runs addiction clinics it has a research partner clinic in Mexico.
Executives
Ian Rabb Senior Officer

Universal Ibogaine (TSXV:IBO) Headlines

No Headlines